AlphaFold redesigns CRISPR proteins to cut gene-editing errors

Gene-editing therapies face a fundamental safety challenge: while guide RNAs can be designed to match specific target sequences, the human genome is large enough that even rare DNA sequences appear by chance. Cas9, the protein that binds to those sequences, can tolerate some mismatches between the guide RNA and DNA without losing its ability to stick. This tolerance varies by location and number of mismatches, making it difficult to predict in advance which guide RNAs might trigger off-target edits. Researchers have pursued several routes to address this—optimizing guide RNA selection, engineering improved Cas proteins through directed evolution, and now, using AI to pinpoint the exact structural features that enable mismatch tolerance.

The team's innovation was to use AlphaFold not merely to visualize protein structures, but to systematically compare structures formed at on-target versus off-target sites. By tracking which amino acids change their contact patterns with RNA when the DNA sequence is mismatched, they identified a small set of positions that consistently adapt. The "ContactSeek" method—comparing contact probability outputs for matched and mismatched scenarios—turned an overwhelming list of candidate amino acids into a focused set of high-impact sites. This allowed rapid testing and successful redesign. Notably, the resulting variant performed similarly to other engineered Cas9 variants in published literature, suggesting the method yields genuinely competitive improvements rather than isolated gains.